行業暴擊不斷 芯片股集體走強 中芯國際(0981.HK)漲超6%
格隆匯5月27日丨台灣芯片行業暴擊不斷,半導體芯片吿急,港A市場半導體芯片板塊不斷拉昇。A股現漲停潮,中晶科技、立昂微、三安光電等漲停;港股中芯國際一度漲超6%,華虹半導體一度漲近9%。台灣疫情升級,26日通報增加633例本土新冠肺炎確診病例,已連續12天新增本土病例超過100例;確診個案中新增11例死亡,創疫情以來單日新高。除疫情外,據悉台灣還面臨乾旱和停電的衝擊,嚴格的供水、不足的電力,讓芯片企業苦不堪言。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.